UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
iShares MSCI Global Gold Miners ETF
RING
$2.5B
| $3.72M | ﹤0.01% |
57,569
+54,495
| +1,773% | +$4.17M |
|
1727
ARS Pharmaceuticals
SPRY
$536M
| $3.7M | ﹤0.01% |
461,384
-3,297
| -0.7% | -$28.4K |
|
1728
ORIX
IX
$40.8B
| $3.69M | ﹤0.01% |
97,086
| – | – |
|
1729
iShares S&P 500 Value ETF
IVE
$49.8B
| $3.69M | ﹤0.01% |
16,259
-17,899
| -52% | -$4M |
|
|
BMNR
1730
BitMine Immersion Technologies
BMNR
$14.9B
| $3.69M | ﹤0.01% |
+277,247
| New | +$5.36M |
|
1731
AtriCure
ATRC
$2.73B
| $3.69M | ﹤0.01% |
131,853
-423,261
| -76% | -$11.9M |
|
1732
Dimensional Core Fixed Income ETF
DFCF
$11.5B
| $3.67M | ﹤0.01% |
87,040
| – | – |
|
1733
Axogen
AXGN
$2.51B
| $3.67M | ﹤0.01% |
79,524
+18,754
| +31% | +$756K |
|
|
AVNS
1734
DELISTED
Avanos Medical
AVNS
| $3.66M | ﹤0.01% |
147,266
-62,894
| -30% | -$1.47M |
|
1735
The Greenbrier Companies
GBX
$1.32B
| $3.66M | ﹤0.01% |
74,696
-1,479
| -2% | -$72.7K |
|
1736
Progress Software
PRGS
$1.73B
| $3.66M | ﹤0.01% |
108,951
+8,012
| +8% | +$237K |
|
1737
Universal Technical Institute
UTI
$1.19B
| $3.65M | ﹤0.01% |
85,421
-14,555
| -15% | -$559K |
|
1738
Carter's
CRI
$1.19B
| $3.64M | ﹤0.01% |
88,531
+8,896
| +11% | +$337K |
|
1739
CTS Corp
CTS
$1.62B
| $3.64M | ﹤0.01% |
55,896
-159
| -0.3% | -$9.54K |
|
1740
Dimensional International High Profitability ETF
DIHP
$6.55B
| $3.63M | ﹤0.01% |
106,255
| – | – |
|
1741
Teladoc Health
TDOC
$1.14B
| $3.62M | ﹤0.01% |
427,286
-54,044
| -11% | -$360K |
|
1742
V2X
VVX
$2.34B
| $3.62M | ﹤0.01% |
48,560
-1,819
| -4% | -$135K |
|
1743
Intapp
INTA
$3.05B
| $3.62M | ﹤0.01% |
143,399
-11,041
| -7% | -$252K |
|
1744
Walker & Dunlop
WD
$1.44B
| $3.61M | ﹤0.01% |
66,046
-7,009
| -10% | -$355K |
|
1745
TriNet
TNET
$3.03B
| $3.61M | ﹤0.01% |
72,930
-532
| -0.7% | -$22.8K |
|
1746
Infosys
INFY
$45.1B
| $3.61M | ﹤0.01% |
344,010
-23,147
| -6% | -$290K |
|
1747
AMN Healthcare
AMN
$1.31B
| $3.6M | ﹤0.01% |
111,096
-2,244
| -2% | -$57.9K |
|
1748
Albany International
AIN
$1.77B
| $3.58M | ﹤0.01% |
48,047
-6,415
| -12% | -$402K |
|
1749
iShares U.S. Large Cap Premium Income Active ETF
BALI
$1.38B
| $3.57M | ﹤0.01% |
105,446
| – | – |
|
1750
Dime Commercial Bancshares
DCOM
$1.8B
| $3.56M | ﹤0.01% |
87,507
-858
| -1% | -$31.9K |
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.